[Research progress on phenotypic modifier genes in spinal muscular atrophy].
Authors:
- 15 February 2025
- journal article
- review article
- Vol. 27 (2) , 229-235
Abstract
Spinal muscular atrophy (SMA) is a common fatal autosomal recessive genetic disorder in childhood, primarily caused by homozygous deletion of the SMN1 gene. Its main characteristics include the degenerative changes in the anterior horn motor neurons of the spinal cord, leading to symmetrical progressive muscle weakness and atrophy of the proximal limbs. However, SMA patients with the same genetic background often exhibit different degrees of disease severity. In addition to the well-established modifier gene SMN2, the effect of other modifier genes on clinical phenotypes should not be overlooked. This paper reviews the latest advancements in the pathogenic and modifier genes of SMA, aiming to provide a deeper understanding of the pathogenic mechanisms and phenotypic differences in SMA, as well as to offer new strategies and targets for treating this condition.Keywords
This publication has 38 references indexed in Scilit:
- Telomeric Region of the Spinal Muscular Atrophy Locus Is Susceptible to Structural VariationsPediatric Neurology, 2016
- Association between SMN2 methylation and disease severity in Chinese children with spinal muscular atrophyJournal of Zhejiang University-SCIENCE B, 2016
- Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamicsHuman Molecular Genetics, 2014
- Correlation of PLS3 expression with disease severity in children with spinal muscular atrophyJournal of Human Genetics, 2013
- Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophyGene, 2013
- Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionalityHuman Molecular Genetics, 2012
- Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathwayJournal of Clinical Investigation, 2011
- A Positive Modifier of Spinal Muscular Atrophy in the SMN2 GeneThe American Journal of Human Genetics, 2009
- Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular AtrophyScience, 2008
- Stat5 constitutive activation rescues defects in spinal muscular atrophyHuman Molecular Genetics, 2007